Barely Significant
← all excerpts

Oncogenic <i>NTRK3</i> mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemia.

Haematologica · 2025 · PMC12208164 · PMID 39945005

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

did not reach statistical significanceno p-value reported
Similar substrates were highlighted for NTRK3 P792S but did not reach statistical significance ( Figure 2C ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.